Crescent Biopharma, Inc.

Crescent Biopharma Announces Grants of Inducement Awards

Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Crescent Biopharma to Present at March Investor Conferences

Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors

Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026